APO Research
Talk to an analyst

APO RESEARCH · REPORT

Monocyte Activation Test

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Monocyte Activation Test Market Outlook and Growth Opportunities 2026

27 December 2025195 pages

Choose your research edition.

Industry ResearchMonocyte Activation Test Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Monocyte Activation Test Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Monocyte Activation Test Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Monocyte Activation Test Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Monocyte Activation Test Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Monocyte Activation Test market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Monocyte Activation Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Monocyte Activation Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Monocyte Activation Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Monocyte Activation Test market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Monocyte Activation Test market include Thermo Fisher Scientific, Landfar, Merck KGaA, Mindray, SOLVIAS AG, Microcoat Biotechnologie GmbH, Lonza Group, Charles River Laboratories International, Inc. and Becton, Dickinson and Company, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Monocyte Activation Test market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Monocyte Activation Test and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Monocyte Activation Test revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Monocyte Activation Test market.

Monocyte Activation Test Segment by Company

Thermo Fisher Scientific

Landfar

Merck KGaA

Mindray

SOLVIAS AG

Microcoat Biotechnologie GmbH

Lonza Group

Charles River Laboratories International, Inc.

Becton, Dickinson and Company

Monocyte Activation Test Segment by Type

MAT Kits

Reagents

Monocyte Activation Test Segment by Application

Biotechnology Industry

Medical Device Industry

Pharmaceutical Industry

Others

Monocyte Activation Test Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Monocyte Activation Test status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Monocyte Activation Test key companies, revenue, market share, and recent developments.

3. To split the Monocyte Activation Test breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Monocyte Activation Test market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Monocyte Activation Test significant trends, drivers, influence factors in global and regions.

6. To analyze Monocyte Activation Test competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Monocyte Activation Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Monocyte Activation Test and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Monocyte Activation Test.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Monocyte Activation Test industry.

Chapter 3: Detailed analysis of Monocyte Activation Test company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Monocyte Activation Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Monocyte Activation Test in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Monocyte Activation Test Industry Trends Table 2. Monocyte Activation Test Industry Drivers Table 3. Monocyte Activation Test Industry Opportunities and Challenges Table 4. Monocyte Activation Test Industry Restraints Table 5. Global Monocyte Activation Test Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Monocyte Activation Test Revenue Share by Company (2021-2026) Table 7. Global Monocyte Activation Test Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Monocyte Activation Test Key Company Manufacturing Base & Headquarters Table 9. Global Monocyte Activation Test Company, Product Type & Application Table 10. Global Monocyte Activation Test Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Monocyte Activation Test by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of MAT Kits Table 15. Significant Companies of Reagents Table 16. Global Monocyte Activation Test Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Monocyte Activation Test Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Monocyte Activation Test Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Monocyte Activation Test Sales Value Share by Type (2021-2026) Table 20. Global Monocyte Activation Test Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Biotechnology Industry Table 22. Significant Companies of Medical Device Industry Table 23. Significant Companies of Pharmaceutical Industry Table 24. Significant Companies of Others Table 25. Global Monocyte Activation Test Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Monocyte Activation Test Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Monocyte Activation Test Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Monocyte Activation Test Sales Value Share by Application (2021-2026) Table 29. Global Monocyte Activation Test Sales Value Share by Application (2027-2032) Table 30. Global Monocyte Activation Test Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Monocyte Activation Test Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Monocyte Activation Test Sales Value Share by Region (2021-2026) Table 33. Global Monocyte Activation Test Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Monocyte Activation Test Sales Value Share by Region (2027-2032) Table 35. Global Monocyte Activation Test Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Monocyte Activation Test Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Monocyte Activation Test Sales Value Market Share by Country (2021-2026) Table 38. Global Monocyte Activation Test Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Monocyte Activation Test Sales Value Market Share by Country (2027-2032) Table 40. Thermo Fisher Scientific Company Information Table 41. Thermo Fisher Scientific Business Overview Table 42. Thermo Fisher Scientific Monocyte Activation Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Thermo Fisher Scientific Monocyte Activation Test Product Portfolio Table 44. Thermo Fisher Scientific Recent Development Table 45. Landfar Company Information Table 46. Landfar Business Overview Table 47. Landfar Monocyte Activation Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Landfar Monocyte Activation Test Product Portfolio Table 49. Landfar Recent Development Table 50. Merck KGaA Company Information Table 51. Merck KGaA Business Overview Table 52. Merck KGaA Monocyte Activation Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Merck KGaA Monocyte Activation Test Product Portfolio Table 54. Merck KGaA Recent Development Table 55. Mindray Company Information Table 56. Mindray Business Overview Table 57. Mindray Monocyte Activation Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Mindray Monocyte Activation Test Product Portfolio Table 59. Mindray Recent Development Table 60. SOLVIAS AG Company Information Table 61. SOLVIAS AG Business Overview Table 62. SOLVIAS AG Monocyte Activation Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. SOLVIAS AG Monocyte Activation Test Product Portfolio Table 64. SOLVIAS AG Recent Development Table 65. Microcoat Biotechnologie GmbH Company Information Table 66. Microcoat Biotechnologie GmbH Business Overview Table 67. Microcoat Biotechnologie GmbH Monocyte Activation Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Microcoat Biotechnologie GmbH Monocyte Activation Test Product Portfolio Table 69. Microcoat Biotechnologie GmbH Recent Development Table 70. Lonza Group Company Information Table 71. Lonza Group Business Overview Table 72. Lonza Group Monocyte Activation Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Lonza Group Monocyte Activation Test Product Portfolio Table 74. Lonza Group Recent Development Table 75. Charles River Laboratories International, Inc. Company Information Table 76. Charles River Laboratories International, Inc. Business Overview Table 77. Charles River Laboratories International, Inc. Monocyte Activation Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Charles River Laboratories International, Inc. Monocyte Activation Test Product Portfolio Table 79. Charles River Laboratories International, Inc. Recent Development Table 80. Becton, Dickinson and Company Company Information Table 81. Becton, Dickinson and Company Business Overview Table 82. Becton, Dickinson and Company Monocyte Activation Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Becton, Dickinson and Company Monocyte Activation Test Product Portfolio Table 84. Becton, Dickinson and Company Recent Development Table 85. Research Programs/Design for This Report Table 86. Authors List of This Report Table 87. Secondary Sources Table 88. Primary Sources List of Figures Figure 1. Monocyte Activation Test Product Image Figure 2. Global Monocyte Activation Test Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Monocyte Activation Test Market Size (2021-2032) & (US$ Million) Figure 4. Global Monocyte Activation Test Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. MAT Kits Image Figure 8. Reagents Image Figure 9. Global Monocyte Activation Test Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Monocyte Activation Test Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Monocyte Activation Test Sales Value Share by Type (2021-2032) Figure 12. Biotechnology Industry Image Figure 13. Medical Device Industry Image Figure 14. Pharmaceutical Industry Image Figure 15. Others Image Figure 16. Global Monocyte Activation Test Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Monocyte Activation Test Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Monocyte Activation Test Sales Value Share by Application (2021-2032) Figure 19. Global Monocyte Activation Test Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Monocyte Activation Test Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Monocyte Activation Test Sales Value (2021-2032) & (US$ Million) Figure 22. North America Monocyte Activation Test Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Monocyte Activation Test Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Monocyte Activation Test Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Monocyte Activation Test Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Monocyte Activation Test Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Monocyte Activation Test Sales Value (2021-2032) & (US$ Million) Figure 28. South America Monocyte Activation Test Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Monocyte Activation Test Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Monocyte Activation Test Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Monocyte Activation Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • MAT Kits
  • Reagents
Applications
  • Biotechnology Industry
  • Medical Device Industry
  • Pharmaceutical Industry
  • Others
Companies covered
  • Thermo Fisher Scientific
  • Landfar
  • Merck KGaA
  • Mindray
  • SOLVIAS AG
  • Microcoat Biotechnologie GmbH
  • Lonza Group
  • Charles River Laboratories International, Inc.
  • Becton, Dickinson and Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Monocyte Activation Test Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Monocyte Activation Test Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Monocyte Activation Test Market Dynamics
  1. 2.1 Monocyte Activation Test Industry Trends
  2. 2.2 Monocyte Activation Test Industry Drivers
  3. 2.3 Monocyte Activation Test Industry Opportunities and Challenges
  4. 2.4 Monocyte Activation Test Industry Restraints
3 Monocyte Activation Test Market by Company
  1. 3.1 Global Monocyte Activation Test Company Revenue Ranking in 2025
  2. 3.2 Global Monocyte Activation Test Revenue by Company (2021-2026)
  3. 3.3 Global Monocyte Activation Test Company Ranking (2024-2026)
  4. 3.4 Global Monocyte Activation Test Company Manufacturing Base and Headquarters
  5. 3.5 Global Monocyte Activation Test Company Product Type and Application
  6. 3.6 Global Monocyte Activation Test Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Monocyte Activation Test Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Monocyte Activation Test Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Monocyte Activation Test Market by Type
  1. 4.1 Monocyte Activation Test Type Introduction
  2. 4.1.1 MAT Kits
  3. 4.1.2 Reagents
  4. 4.2 Global Monocyte Activation Test Sales Value by Type
  5. 4.2.1 Global Monocyte Activation Test Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Monocyte Activation Test Sales Value by Type (2021-2032)
  7. 4.2.3 Global Monocyte Activation Test Sales Value Share by Type (2021-2032)
5 Monocyte Activation Test Market by Application
  1. 5.1 Monocyte Activation Test Application Introduction
  2. 5.1.1 Biotechnology Industry
  3. 5.1.2 Medical Device Industry
  4. 5.1.3 Pharmaceutical Industry
  5. 5.1.4 Others
  6. 5.2 Global Monocyte Activation Test Sales Value by Application
  7. 5.2.1 Global Monocyte Activation Test Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Monocyte Activation Test Sales Value by Application (2021-2032)
  9. 5.2.3 Global Monocyte Activation Test Sales Value Share by Application (2021-2032)
6 Monocyte Activation Test Regional Value Analysis
  1. 6.1 Global Monocyte Activation Test Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Monocyte Activation Test Sales Value by Region (2021-2032)
  3. 6.2.1 Global Monocyte Activation Test Sales Value by Region: 2021-2026
  4. 6.2.2 Global Monocyte Activation Test Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Monocyte Activation Test Sales Value (2021-2032)
  7. 6.3.2 North America Monocyte Activation Test Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Monocyte Activation Test Sales Value (2021-2032)
  10. 6.4.2 Europe Monocyte Activation Test Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Monocyte Activation Test Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Monocyte Activation Test Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Monocyte Activation Test Sales Value (2021-2032)
  16. 6.6.2 South America Monocyte Activation Test Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Monocyte Activation Test Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Monocyte Activation Test Sales Value Share by Country, 2025 VS 2032
7 Monocyte Activation Test Country-level Value Analysis
  1. 7.1 Global Monocyte Activation Test Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Monocyte Activation Test Sales Value by Country (2021-2032)
  3. 7.2.1 Global Monocyte Activation Test Sales Value by Country (2021-2026)
  4. 7.2.2 Global Monocyte Activation Test Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Monocyte Activation Test Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Monocyte Activation Test Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Monocyte Activation Test Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Monocyte Activation Test Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Monocyte Activation Test Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Landfar
  8. 8.2.1 Landfar Company Information
  9. 8.2.2 Landfar Business Overview
  10. 8.2.3 Landfar Monocyte Activation Test Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Landfar Monocyte Activation Test Product Portfolio
  12. 8.2.5 Landfar Recent Developments
  13. 8.3 Merck KGaA
  14. 8.3.1 Merck KGaA Company Information
  15. 8.3.2 Merck KGaA Business Overview
  16. 8.3.3 Merck KGaA Monocyte Activation Test Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck KGaA Monocyte Activation Test Product Portfolio
  18. 8.3.5 Merck KGaA Recent Developments
  19. 8.4 Mindray
  20. 8.4.1 Mindray Company Information
  21. 8.4.2 Mindray Business Overview
  22. 8.4.3 Mindray Monocyte Activation Test Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mindray Monocyte Activation Test Product Portfolio
  24. 8.4.5 Mindray Recent Developments
  25. 8.5 SOLVIAS AG
  26. 8.5.1 SOLVIAS AG Company Information
  27. 8.5.2 SOLVIAS AG Business Overview
  28. 8.5.3 SOLVIAS AG Monocyte Activation Test Revenue and Gross Margin (2021-2026)
  29. 8.5.4 SOLVIAS AG Monocyte Activation Test Product Portfolio
  30. 8.5.5 SOLVIAS AG Recent Developments
  31. 8.6 Microcoat Biotechnologie GmbH
  32. 8.6.1 Microcoat Biotechnologie GmbH Company Information
  33. 8.6.2 Microcoat Biotechnologie GmbH Business Overview
  34. 8.6.3 Microcoat Biotechnologie GmbH Monocyte Activation Test Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Microcoat Biotechnologie GmbH Monocyte Activation Test Product Portfolio
  36. 8.6.5 Microcoat Biotechnologie GmbH Recent Developments
  37. 8.7 Lonza Group
  38. 8.7.1 Lonza Group Company Information
  39. 8.7.2 Lonza Group Business Overview
  40. 8.7.3 Lonza Group Monocyte Activation Test Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lonza Group Monocyte Activation Test Product Portfolio
  42. 8.7.5 Lonza Group Recent Developments
  43. 8.8 Charles River Laboratories International, Inc.
  44. 8.8.1 Charles River Laboratories International, Inc. Company Information
  45. 8.8.2 Charles River Laboratories International, Inc. Business Overview
  46. 8.8.3 Charles River Laboratories International, Inc. Monocyte Activation Test Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Charles River Laboratories International, Inc. Monocyte Activation Test Product Portfolio
  48. 8.8.5 Charles River Laboratories International, Inc. Recent Developments
  49. 8.9 Becton, Dickinson and Company
  50. 8.9.1 Becton, Dickinson and Company Company Information
  51. 8.9.2 Becton, Dickinson and Company Business Overview
  52. 8.9.3 Becton, Dickinson and Company Monocyte Activation Test Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Becton, Dickinson and Company Monocyte Activation Test Product Portfolio
  54. 8.9.5 Becton, Dickinson and Company Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst